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Background: Sickle cell disease (SCD) is a genetic disease caused by an individual inheriting an allele for sickle cell
hemoglobin from both parents and is associated with unusually large numbers of immature blood cells, containing
many long, thin, crescent-shaped erythrocytes. It is a disease prevalent throughout many populations. The use of
medicinal plants and nutrition in managing SCD is gaining increasing attention.
Methods: The antisickling effects of Solenostemon monostachyus (SolMon), Carica papaya seed oil (Cari-oil) and
Ipomoea involucrata (Ipocrata) in male (HbSSM) and female (HbSSF) human sickle cell blood was examined in vitro
and compared with controls, or cells treated with glutathione or an antisickling plant (Vernonia amygdalina;
VerMyg).
Results: Levels of sickle blood cells were significantly reduced (P < 0.05) in all the plant-extract treated SCD
patients’ blood compared with that of untreated SCD patients. RBCs in SolMon, Ipocrata, and Cari-oil treated
samples were significantly higher (P < 0.05) compared with VerMyg-treated samples. The Fe2+/Fe3+ ratio was
significantly reduced (P < 0.05) in all plant extract-treated HbSSM samples compared with controls. Hemoglobin
concentration was significantly increased (P < 0.05) by SolMon treatment in HbSSF compared with VerMyg. Sickle
cell polymerization inhibition exhibited by SolMon was significantly higher (P < 0.05) compared with that of
VerMyg in HbSSF blood. Sickle cell polymerization inhibition in SolMon and Ipocrata were significantly higher
(P < 0.05) compared with VerMyg in HbSSM blood. All plant extracts significantly reduced (P < 0.05) lactate
dehydrogenase activity in both HbSSM and HbSSF-treated blood. Catalase activity was significantly increased
(P < 0.05) in HbSSF blood treated with Ipocrata compared with glutathione. Cari-oil treated HbSSM and HbSSF
blood had significantly increased (P < 0.05) peroxidase activity compared with controls.
Conclusions: Methanolic extracts from S. monostachyus, C. papaya seed oil and I. involucrata exhibited particular
antisickling properties coupled with the potential to reduce stress in sickle cell patients. Each plant individually or in
combination may be useful for the management of sickle cell disease.
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The practice of traditional medicine using medicinal
plants has a long history in many cultures. This type of
health care can be described as herbalism or botanical
medicine [1]. The growing sophistication in lifestyles
among world populations makes it imperative to refer to
herbal practice as alternative or complementary medi-
cine, to appeal to a cross section of people irrespective
of their cultural affiliation [1]. This type of herbal prac-
tice is gaining increasing attention [1]. Two-thirds of the
world’s population (mainly in developing countries) re-
lies entirely on such traditional medical therapies as
their primary form of health care [2]. The use of trad-
itional medicine is important for the treatment and
management of a number of diseases in the African con-
tinent [3], as a lack of basic health care and medical
personnel make it difficult to treat rural populations.
Sickle cell disease (SCD) is an autosomal recessive
genetic disease caused by a mutation in the hemoglobin
gene and is associated with shortness of breath, heart
palpitations, abdominal pains, and muscular aches and
pains [4]. Blood of sickle cell patients contains an un-
usually large number of immature cells and many long,
thin, crescent-shaped erythrocytes that resemble the
blade of a sickle [5]. When hemoglobin from sickle cells
(called hemoglobin S) is deoxygenated, it becomes insol-
uble and forms polymers that aggregate to tubular fibers.
The altered properties of hemoglobin S result from a
single amino acid substitution of valine to glutamate at
position 6 in the two hemoglobin chains [5]. The R
group of valine has no electric charge, whereas glutam-
ate has a negative charge at pH 7.4. Therefore,
hemoglobin S has two fewer negative charges than
hemoglobin A, one for each of the two chains. Replace-
ment of the glutamate residue by valine creates a “sticky”
hydrophobic contact point at position 6 of the chain, on
the outer surface of the molecule. These sticky spots
cause deoxyhemoglobin S molecules to associate abnor-
mally with each other, forming long, fibrous aggregates
characteristic of this disorder [6]. Increased free intracel-
lular Ca2+ occurs during SCD [7], resulting in a loss of K
+ with accompanying changes in levels of Cl- ions and
water, and a corresponding gain of Na+. Small blood ves-
sels are blocked by the clumping of sickle red blood cells
(RBCs), preventing blood supply to various organs [1].
The anti-sickling effects of various substances and the
role of nutrition in overcoming SCD have been reported
[8-10], although information on the management of
SCD is still scarce. The antioxidant capability of Solenos-
temon monostachyus, Ipomoea involucrata, and Carica
papaya seed oil has recently been reported [11-13].
Some plants and herbs with potent antioxidant activity,
including the leaf of Vernonia amygdalina and unripe C.
papaya fruit, have been reported to have antisicklingproperties [14,15]. However, the antisickling properties
of C. papaya seed oil, I. involucrata and S. monostachyus
leaves have not been reported. This study examined the
antisickling effects of aqueous methanolic extracts of
leaves from these three plants on human sickle cell
blood in vitro.Methods
Chemicals
Glucose-6-phosphate dehydrogenase (G6PDH) kit and
lactate dehydrogenase (LDH) kit were obtained from
Randox Laboratories Ltd. (Crumlin, United Kingdom).
Methanol and liquid paraffin were obtained from British
Drug House Chemicals Limited (Poole, United Kingdom).
Hydrogen peroxide (H2O2) was obtained from Merck
Inc (Lehrte, Germany), and pyrogallol, and glutathione
were obtained from Sigma Chemical Incorporation
(Munich, Germany). All chemicals used were of analyt-
ical grade.Collection of plant materials
S. monostachyus (P. Beauv) Brig. (SoleMon; FHI108913),
I. involucrata P. Beauv. (Ipocrata; FHI 108917), mature
ripe C. papaya fruits (Cari; FHI108906) and V. amygda-
lina Del. (VerMyg; FHI 108914) plants were collected
between 21st November and 2nd December, 2011 within
the lawns of Covenant University, Ota, Ogun State, Ni-
geria. These plants were identified at the Applied Biol-
ogy Unit of the Biological Sciences Department at
Covenant University. They were reconfirmed and depos-
ited at the Herbarium unit of the Forest Research Insti-
tute of Nigeria (FRIN), Ibadan, Nigeria. The allocated
voucher numbers for each of the plants deposited at
FRIN are as indicated above for each plant. The samples
were air dried at ambient temperature (37.8 ± 4.7°C) and
turned over regularly to aid in the drying process over a
period of 2 weeks. Seeds harvested from the C. papaya
fruits were oven died at 35–37°C for 2 weeks. The dried
plants were blended into powdered form using the dry
program of a blender (Emel EM-242) and stored in clean
air-tight containers prior to use.Preparation of methanolic extracts from plants
Preparation of methanolic extracts from plants was car-
ried out using a previously described method with some
modifications [15]. Dried samples (90 g) were macerated
in 1200 ml of methanol (absolute) for 72 h at room
temperature. These were consecutively filtered using
cotton wool, a Whatman filter paper (no. 1), and there-
after with a Vane pressure/vacuum pump filtration de-
vice (XZ-1B). The collected filtrates were evaporated in
vacuo using a rotary evaporator (Stuart RE: 300) at 20°C.
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Dried extracts (0.1 g) were re-dissolved in 5 ml of abso-
lute methanol, and filtered using Whatman filter paper
(no. 1). The filtrates were then used as the working anti-
sickling agent.Collection of blood samples and preparation of serum
samples
Sickle cell blood (HbSS) samples from males and females
were obtained from General Hospital, Gbagada, Lagos
State. The blood samples were collected from confirmed
sickle cell patients attending a weekly hematology out-
patient clinic at the hospital. Blood samples for healthy
males (NBM) and females (NBF) were obtained from the
Covenant University Health Center, Canaan Land, Ota,
Ogun State, Nigeria. The blood samples were collected
from healthy students for this study. The permission of
Covenant University Ethical Committee was obtained
prior to the commencement of this work. Consent from
all blood donors were obtained after they were ad-
equately informed of the research objective. Hospital
ethical regulations were observed when blood was
collected.
The venipuncture method was used for blood collec-
tion as described previously [15]. Blood (4 ml) was
drawn from each sickle cell patient (ages 15 to 48 years)
at steady state using new syringes and needles, spirit
swaps and a tourniquet. The blood samples were col-
lected into EDTA and plain bottles and the collected
blood was subsequently inverted gently for mixing. The
same procedure was used to collect blood from con-
firmed normal healthy blood donors selected randomly
in Covenant University, except they were 18 to 23 years
of age. All experiments were performed within 72 h of
blood collection. The blood samples collected were cen-
trifuged at 10 000 rpm for 15 minutes to obtain plasma
samples (2.0 ml).Packed cell volume (PCV)
Fresh blood samples were collected and dispensed to fill
about ¾ of a micro hematocrit tube (75 μL), and plasticine
was used to block the opening to avoid spillage during cen-
trifugation at 12 000 rpm for 5 min. PCV was measured
using a hematocrit reader.Preparation of RBC
One drop of blood obtained after removing plasma was
applied to a microscope slide using a Pasteur pipette.
The erythrocyte sample was then spread using the tip of
the Pasteur pipette. The slides were left to dry, and
stained with Leishman’s stain. The slides were kept until
used for cell counting.Sickle cell reversal
The extent of sickle cell reversal was determined as pre-
viously described [15]. HbSS blood (0.2 ml) was placed
in a test tube, and 0.2 ml phosphate buffered solution
(PBS, 0.05M, pH 8.0) was added. The mixture was cov-
ered with liquid paraffin (1.0 ml). 2% sodium metabisul-
fite solution (0.6 ml) was introduced into the blood layer
under the liquid paraffin using a syringe and needle. The
mixture was gently mixed before incubating at 37°C in a
thermostated water bath for 90 min. At the end of this
incubation period, the methanolic extract (0.2 ml) of
each plant was added under the liquid paraffin carefully
as before and incubated for another 6 h. A 0.2 ml aliquot
of PBS and 0.2 ml of blood collected from healthy
donors were used in place of the extracts, and HbSS
blood respectively to serve as a control. The liquid paraf-
fin layer was carefully removed using a Pasteur pipette
and 5% buffered formalin solution (3 ml) was added at
the end of the 6-h incubation. The solution was thor-
oughly mixed to ensure proper fixation and was kept at
ambient temperature until ready for counting. The slide
was mounted on a camera equipped Lab Biological
microscope (Model N-800M) supplied by Tunnex La-
boratory Nigeria Limited (Lagos, Nigeria). The number
of RBCs and sickle cells were counted to monitor the
level of sickling reversal of each plant treatment. The
sickling reversal activity for each plant was monitored by
calculating their percentage sickle cell blood level using
the formula below:
Sickle cell blood level %ð Þ ¼ HbSS counted=
HbSS counted þ RBC countedð Þ  100
Determination of glucose-6-phosphate dehydrogenase
(G6PDH) activity
The G6PDH activity was measured according to the
manufacturer’s instructions. Fresh blood samples
(0.2 ml) were washed with aliquots of 0.9% sodium
chloride solution (2 ml) and centrifuged at 300 rpm
for 10 min. The washing process was repeated three
times. The erythrocyte residue was then suspended
in 0.5 ml of digitonin (solution 4 of the G6PDH kit)
that had been previously dispensed into an eppen-
dorf tube. After standing for 15 min the suspended
erythrocytes were centrifuged again at 300 rpm for
10 min. An aliquot of the hemolysate (15 μl) was
added to Reagent R1 buffer (1000 μl), and NADP
reagent 2 (30 μl) of the G6PDH kit. The mixture
was shaken and incubated at 37°C for 5 min. The
initial absorbance was measured at 340 nm immedi-
ately after adding the substrate reagent R3 (15 μl).
Distilled water was used as a blank. Changes in the
absorbance at 340 nm were measured every min for
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indicated below following the method described by
the kit manufacturer.
G6PDH activity mU=erythrocytes per ml bloodð Þ
¼ 33650 Δ absorbance340nm=min
Determination of Fe2+/Fe3+ ratio of sickle cell blood
The effect of the different plant extracts on the Fe2+/Fe3+
ratios in blood were performed as previously described
[8]. An aliquot of sickle cell blood (20 μl) was added
to distilled water (5.0 ml) and normal saline (20 μl)
to serve as a control. The standard and test solutions
contained the same reagents as the control except
that an aliquot of the plant extract (20 μl) was added
instead of normal saline. Samples were incubated for
60 min and the absorbance measured by spectropho-
tometer at wavelengths of 540 nm and 630 nm to deter-
mine the percent hemoglobin and methemoglobin
respectively. The ratio of hemoglobin and methemoglobin
was calculated by dividing the percentage hemoglobin
by that of methemoglobin.
Determination of sickle cell polymerization inhibition
Sickle cell polymerization inhibition was carried out as
described previously with modifications [8]. Briefly,
blood samples from confirmed homozygous SCD
patients (HbSS) were hemolyzed by freeze thawing, and
subsequently centrifuged at 10 000 rpm for 9 min. The
supernatant (hemoglobin) obtained was placed in vials
and stored at 4°C. An aliquot of 1.4 ml sodium metabi-
sulfite solution (2% w/v), 80 μl of plant extract (serving
as antisickling agent), and HbSS hemoglobin (0.1 ml)
were pipetted into a cuvette, shaken and the absorbance
measured at 700 nm for 30 min. The same reagents
were set up for the controls, except that the plant ex-
tract was replaced with the same amount of normal sa-
line (0.5 N). The rates of polymerization were estimated
by calculating the rate of change in absorbance per
minute.
Determination of lactate dehydrogenase (LDH) activity
This was outperformed according to the manufac-
turer’s instructions. An aliquot of the plant extract
(20 μl) was dispensed into a cuvette containing the
kit reagent (1.0 ml), and serum samples (40 μl) of
the HbSS patients. Serum samples from healthy
contributors were used for the control. All the reac-
tions were carried out at 25°C. The initial absorb-
ance at 340 nm was taken within 30 s, and the
absorbance changes were taken afterwards at every
1 min for 3 min. The LDH activity was calculatedusing the formula below as provided by the LDH kit
manufacturer.
LDH activity U=Ið Þ ¼ 4127
 Δ Absorbance 340 nm=min
Determination of catalase activity
Catalase activity of plant extracts on human blood was
assayed as previously described with modifications [16].
Briefly, an aliquot of hydrogen peroxide (0.8 ml) was dis-
pensed into an eppendorf tube. Phosphate buffer (1.0
ml), extracted sample (75 μl) and (0.002% v/v) diluted
blood (125 μl) were added. The reaction mixture (0.5
ml) was dispensed into 5% dichromate reagent (1.0 ml)
and vigorously shaken. The mixture was heated in a Clifton
water bath for ten min, and allowed to cool. The initial
absorbance at 570 nm was taken within 10 s of adding
the substrate, and at 60 s and 120 s using a Surgispec
spectrophotometer (SM-23A). Glutathione was used as a
positive control for the tests. The absorbances obtained
were extrapolated from a prepared standard graph. The
catalase activity was thereafter expressed as μmole/min
using the following formula:
Activity μmole=minð Þ ¼ Δ optical density
H202standard concentration μmolð Þ
=enzyme volume mlð Þ  standard optical density
Determination of peroxidase activity
Peroxidase activity was determined as previously
described [17]. An aliquot of PBS (0.1 ml), hydrogen per-
oxide (50 μl), and pyrogallol solution (110 μl) were
added to distilled water (625 μl) that was earlier dis-
pensed into an eppendorf tube. The plant extract (75 μl)
was thereafter added. The same reagents were used, ex-
cept the extract was replaced by distilled water (75 μl),
for the blank. The reaction was mixed and incubated for
at least 10 min. The solution containing 100 mM, pH
6.0 PBS (40 μl) and 0.002% (v/v) diluted blood sample
(40 μl) were added to the blank and test mixtures re-
spectively. These were mixed, and the increase in ab-
sorbance at 420 nm was measured at every 10 s for 3
min using a Surgispec spectrophotometer (SM-23A).
Glutathione was used as a positive control for the tests.
One unit of peroxidase was defined as the change in ab-
sorbance/seconds at 420 nm.
Statistical analysis
One factor randomized complete block design was used
for this experiment. Data were analyzed using analysis of
variance (ANOVA) MegaStat statistical software package
supplied by Dataville Solutions Ltd. (Lagos, Nigeria).
Treatments with a P value of < 0.05 were considered
Table 1 Clinical features of blood collected from sickle
cell patients and healthy donors
Parameters Healthy Blood Sickle Blood
Male Female Male Female
PCV (%) 43.20 ± 2.74 32.90 ± 3.28 22.70 ± 8.27 23.90 ± 5.76
G6PDH (mU/
ml)
55.81 ± 16.24 56.71 ± 13.94 147.30 ± 16.20 69.34 ± 12.88
Data expressed as mean ± SD (n = 10).
G6PDH = glucose-6-phosphate dehydrogenase; PCV = packed cell volume.
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t-test using the same statistical software. The results
were expressed as mean ± standard deviation.Results
Effect of plant methanolic extract-treatment on PVC
The PCV in NBM was significantly higher (P < 0.05)
compared with that of NBF blood donors. The PCV in
HbSSM or HbSSF was significantly lower (P < 0.05)
compared with either NBM or NBF blood (Table 1). Sickle
blood cell counts were significantly reduced (P < 0.05) in
all the plant-extract treated SCD patients’ blood com-
pared with that of untreated SCD patients’ blood. Plant
extract-treated sickle cell blood had significantly higher
(P < 0.05) numbers of sickle blood compared with that
of healthy blood donors. However, there was no signifi-
cant difference (P > 0.05) in the number of sickle RBCs
for all plant extract-treated groups compared with VerMyg
(Table 2). Only the Ipocrata-treated group had a signifi-
cantly higher (P<0.05) percentage of sickle cell blood
compared with that of the V. amygdalina group.
The number of RBCs per 10 fields of view were sig-
nificantly lower (P < 0.05) in the VerMyg and Ipocrata
extract-treated sickle blood compared with that of
healthy blood donors, whereas the number of RBCs per
10 fields of view in SolMon-, Ipocrata- and Cari-oil-
treated groups were significantly higher (P < 0.05) com-
pared with that of VerMyg (Table 2). Images of untreated
sickle cell blood and blood samples treated with methano-
lic extracts of Ipocrata, SolMon, Cari-oil and VerMyg are
shown in Figures 1, 2, 3, 4 and 5, respectively.Table 2 Blood counts in healthy donors and sickle cell patien
Sample Blood count
No. of Sickle cell RBC
Control (healthy donor) 0.00 ± 0.00
Control (untreated HbSS) 246.20 ± 30.77
Vernonia amygdalina 20.00 ± 10.27
Ipomoea involucrate 33.60 ± 9.89
Solenostemon monostachyus 18.40 ± 4.16
Carica papaya seed-oil 12.40 ± 6.11
Data expressed as mean ± SD (n = 5). RBC = red blood cell. HbSS = human sickle cEffect of plant methanolic extract-treatment on G6PDH
activity, Fe2+/Fe3+ ratios and hemoglobin concentration
The G6PDH activity in HbSSM was significantly higher
(P < 0.05) compared with NBM and NBF samples
(Table 1). The Fe2+/Fe3+ ratios in HbSSM were signifi-
cantly reduced (P < 0.05) by all the plant extract-
treatments compared with control (HbSSM without
extract) (Table 3). Hemoglobin concentration was sig-
nificantly increased (P < 0.05) in HbSSM groups treated
with any of the plant extracts compared with VerMyg
(Table 3). However, hemoglobin concentrations were
only significantly increased (P < 0.05) by SolMon in
HbSSF compared with VerMyg. There was no significant
effect (P > 0.05) of the plant extract-treatment on Hb/
Met-Hb ratios in either HbSSM or HbSSF blood.Effect of plant methanolic extract-treatment on LDH
activity and inhibition of sickle cell polymerization
Inhibition of sickle cell polymerization in HbSSF was
significantly increased (P < 0.05) by all the plant extract-
treatments studied, compared with the control (HbSSF
treated with saline solution). However, SolMon treat-
ment alone significantly inhibited (P < 0.05) sickle cell
polymerization in HbSSM compared with the controls
(Table 3). In HbSSF, sickle cell polymerization inhibition
by SolMon plant extract was significantly higher
(P < 0.05) compared with VerMyg treatment. However,
in HbSSM, sickle cell polymerization inhibition was sig-
nificantly higher (P < 0.05) in the SolMon and Ipocrata-
treated groups compared with that of VerMyg (Table 3).
All the plant extracts significantly reduced (P < 0.05)
LDH activity in HbSSM and HbSSF treated blood
(Table 4).Effect of plant methanolic extract-treatment on blood
catalase and peroxidase activity
Higher catalase activity was found in NBF than that of
the NBM (Table 5). All plant extract treatments, includ-
ing glutathione, significantly reduced (P < 0.05) catalase
activity in NBF compared with the control (NBF without
extract) (Table 5). However, Cari-oil, VerMyg andts treated with some plant extracts
Sickle cell
level (%)No. of RBC per 10 field
958.00 ± 10.95 0.00
670.00 ± 23.91 26.85 ± 3.12
654.40 ± 98.62 2.42 ± 1.11
864.60 ± 46.17 4.04 ± 0.71
851.00 ± 111.66 1.90 ± 0.43
961.40 ± 157.70 1.03 ± 0.16
ell blood.
Figure 1 Picture of blood collected from a sickle cell blood
(Magnification: x1000).
Figure 3 Picture of sickle cell patient blood treated with
Solenostermon monostachyus (Magnification: x1000).
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catalase activity compared with the glutathione standard
(Table 5). In NBM, Cari-oil, Ipocrata, and glutathione
significantly reduced (P < 0.05) the catalase activity com-
pared with the control (NBM without extract) (Table 5),
whereas VerMyg extract significantly increased (P < 0.05)
the catalase activity in NBM compared with the control
(NBM without extract). Furthermore, the SolMon, Cari-
oil and VerMyg treated NBM had significantly higher
(P < 0.05) catalase activity compared with the glutathi-
one group (Table 5). Interestingly, no significant effect
(P > 0.05) of glutathione or plant extract treatments
were observed on catalase activity in HbSSM compared
with the control (HbSSM without extract) (Table 5). In
HbSSF, only glutathione significantly reduced (P < 0.05)
the catalase activity compared with the control (HbSSF
without extract), although the catalase activity was sig-
nificantly increased in HbSSF treated with Ipocrata
compared with glutathione (Table 5).
Both Cari-oil and Ipocrata significantly increased
(P < 0.05) peroxidase activity in NBM and NBF com-
pared with their respective control (blood without ex-
tract) (Table 6). Similar significant increases (P < 0.05) in
peroxidase activity by Cari-oil and Ipocrata treatmentFigure 2 Picture of sickle cell patient blood treated with
Ipomoea involucrata (Magnification: x1000).were also observed in NBM and NBF compared with
glutathione treatment (Table 6). Only SolMon treatment
significantly reduced (P < 0.05) the peroxidase activity in
both NBM and NBF compared with glutathione (Table 6).
Cari-oil treated HbSSF had significantly increased
(P < 0.05) peroxidase activity compared with both the
control (HbSSF without extract) and glutathione groups
(Table 6), but in HbSSM it only induced a significant in-
crease (P < 0.05) in peroxidase activity when compared
with control (HbSSM without extract) (Table 6). There
was no significant effect (P > 0.05) on peroxidase activity
in HbSSM treated with any of the plant extracts when
compared with the glutathione group.
Discussion
The discovery of alternate or synergistic therapy for the
treatment of SCD due to increasing concerns regarding
its effect on the health of individuals worldwide is gain-
ing attention. Higher PCV was observed in healthy male
blood compared with healthy female blood (Table 1).
This confirmed the findings of an earlier report [18,19].
The mean PCV values in normal healthy individuals
range from 42 to 45% in adult males, 36-48% in adult
females, and 32 to 65% in children. Values lower thanFigure 4 Picture of sickle cell patient blood treated with Carica
papaya seed oil (Magnification: x1000).
Figure 5 Picture of sickle cell patient blood treated with
Vernonia amygdalina (Magnification: x1000).
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observed in HbSSM and HbSSF compared with NBM
and NBF may be attributed to the high rate of hemolysis
in HbSS blood [21] that leads to a shortened life span
(15.2 ± 6.3 days) of sickle cell blood compared with nor-
mal blood (90-120 days) [22]. Similar to the reduction in
sickle blood cell counts induced by VerMyg (2.42 ±
1.11%), Cari-oil, SolMon and Ipocrata also effectively
reduced the numbers of sickle blood cells in the un-
treated sickle cell patients’ blood (26.85 ± 3.12%) to that
of 1.03 ± 0.16, 1.90 ± 0.43 and 4.04 ± 0.71% respectively.
All plant extract treatments had greater antisickling effi-
cacy compared with previous reports using extracts from
the antisickling plant (VerMyg). However, these extracts
did not completely reverse sickling since sickle blood
cells still existed in HbSSM and HbSSF blood compared
with normal healthy controls (Table 2). Treatment with
SolMon, Ipocrata, and Cari-oil extracts had similar anti-
sickling properties to VerMyg since higher normal RBC
levels were observed in the treated sickle blood com-
pared with untreated sickle blood. This is evident in the
images of Ipocrata (Figure 2), SolMon (Figure 3) and
Cari-oil (Figure 4) treated HbSS blood, where fewer
numbers of sickle blood cells were observed compared
with the large amount of normal RBCs. However,
Ipocrata treatment was less effective compared with
VerMyg treatment as measured by the number ofTable 3 The effect of selected plant extracts on the chemical
Treatment Fe2+/Fe3+ Ratio Hemoglobin
concentration (%)
Male Female Male Fem
Control 9.94 ± 5.07 5.34 ± 1.40 NT NT
Vernonia amygdalina 4.49 ± 1.29 3.66 ± 1.53 15.34 ± 7.34 29.52
Ipomoea involucrata 3.45 ± 1.19 2.78 ± 1.82 34.25 ± 8.59 51.99
Solenostemon monostachyus 2.33 ± 0.49 1.48 ± 0.33 43.16 ± 17.51 132.7
Carica papaya seed oil 4.52 ± 1.83 3.00 ± 0.96 25.33 ± 8.37 34.22
Data expressed as mean ± SD (n = 10). Hb = hemoglobin; Met-Hb= methemoglobinpercentage of sickle cells present in the blood sample
(Table 2). In this study, three plants (SolMon, Ipomea
and Cari-oil) were shown to have novel antisickling
properties. The antisickling property of Cari-oil was
expected since the antisickling properties of C. papaya
fruits was previously reported [15]. This study also
demonstrated that the seed oil from C. papaya also pos-
sesses antisickling properties. The levels of aggregation
were reduced in all the plant extract-treated HbSS blood
compared with that of untreated HbSS blood (Figures 1,
2, 3, 4 and 5).
The high prevalence of HbSS diseases and G6PDH
deficiency (A- type) in tropical areas is related to the
selective advantage these diseases provide against mal-
aria [23]. The protective effect of HbSS against malaria
has been attributed to heme oxygenase-1 (HO-1), an en-
zyme whose expression is strongly induced by sickle
hemoglobin [24]. G6PDH deficiency screening among
SCD patients has provided the opportunity to administer
appropriate preventive and therapeutic measures [25].
G6PDH activity in HbSSM was higher compared with
either healthy male or female donor blood (Table 1),
suggesting that male HbSS patients may be more sus-
ceptible to malaria than female HbSS patients may. A
higher prevalence of malaria was reported in males than
in females [26-28]. Symptomatic patients are almost ex-
clusively male, due to the X-linked pattern of inheritance
[29]. Therefore, G6PDH deficiency may be more preva-
lent in HbSS females than in HbSS males, and suggests
why a higher occurrence of SCD-associated hemolytic
crises (anemia, pain, jaundice) often occurs in female
HbSS patients [30].
An increase in Fe2+/Fe3+ratios upon application of a
drug or plant extract indicates a reversal of sickling,
suggesting conversion of deoxyHbS to oxyHbS [31].
Fe2+/Fe3+ ratios were reduced by all methanolic plant ex-
tract treatments in HbSS males (Table 3), suggesting they
may decrease the oxygen affinity of RBCs in HbSS male
patients [31]. All plant extract treatments generally led
to an increase in hemoglobin concentrations in HbSS
female patients (Table 3). Interestingly, SolMon and
Ipocrata treatments were more effective than VerMyg forproperties of sickle cell blood
Hb/Met-Hb ratio (× 10-1) Sickle cell
polymerization
inhibition (× 10-4) (Unit/min)
ale Male Female Male Female
NT NT 8.50 ± 7.00 0.00 ± 0.00
± 16.01 0.91 ± 0.47 4.59 ± 3.44 16.43 ± 4.12 21.50 ± 6.61
± 26.89 1.01 ± 0.47 2.69 ± 1.85 6.00 ± 4.29 18.50 ± 10.12
8 ± 97.61 0.88 ± 0.31 1.85 ± 0.49 41.33 ± 9.28 94.00 ± 17.28
± 18.26 1.44 ± 0.84 2.72 ± 1.74 14.50 ± 9.69 15.50 ± 6.27
; NT = not tested.
Table 4 The effect of methanolic plant extracts on lactate
dehydrogenase activity of human sickle cell blood
Treatment Lactate dehydrogenase activity (U/L)
Male Female
Control 204.70 ± 35.09 123.81 ± 37.97
Vernonia amygdalina 9.90 ± 6.26 12.13 ± 4.48
Ipomoea involucrate 6.95 ± 1.01 3.90 ± 3.79
Solenostemon monostachyus 6.19 ± 5.07 4.23 ± 2.42
Carica papaya seed oil 152.70 ± 45.77 14.03 ± 8.56
Data expressed as mean ± SD (n = 5).
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SolMon treatment was more effective than VerMyg in
HbSSF.
One particular area of focus in the management of
SCDs is the inhibition of sickle cell hemoglobin
polymerization. It was hypothesized that an ideal anti-
sickling drug or agent should significantly inhibit
polymerization of the sickle cell hemoglobin in SCD
blood [32]. Apart from inhibiting polymerization, the
agent should also increase the oxygen affinity of
hemoglobin. In this study, polymerization was inhibited
by VerMyg plant extract treatment in male SCD patients
(Table 3). This was expected as the plant had previously
been reported to have antisickling properties [14]. Simi-
larly, SolMon exhibited a remarkable ability to inhibit
sickle cell polymerization in male SCD patients (Table 3).
Of note, all plant extracts tested in this study inhibited
sickle cell polymerization in HbSSF. Importantly, the po-
tency of SolMon to inhibit sickle cell hemoglobin
polymerization exceeded that of VerMyg in HbSSF as
previously described (Table 3).
The effect of plant extracts on oxidative stress in Sickle
cell patient bloods
Lactate dehydrogenase
LDH is an important enzyme for carbohydrate metabol-
ism and is used as an indicative criterion for exposure to
chemical stress [33]. All plant extracts in this study
reduced LDH activity in sickle cell blood (Table 4).Table 5 Catalase activity in plant extract-treated sickle cell an
Treatment
Healthy blood dono
Male
Control 46.40 ± 6.37 15
Glutathione 5.33 ± 4.44
Vernonia amygdalina 69.69 ± 10.08 2
Ipomoea involucrata 8.53 ± 0.00 3
Solenostemon monostachyus 34.13 ± 13.32 1
Carica papaya seed oil 14.93 ± 5.64 4
Data expressed as mean ± SD (n = 10).Reduced LDH activity levels in treated HbSS blood sam-
ples (Table 4) indicate a lower energy metabolism of
RBCs [34]. In addition, all plant extracts facilitated bio-
chemical changes that enhanced oxidative interactions
in HbSS blood, indicating anaerobic fermentation in
RBCs [33]. Therefore, the plants studied here possess
the ability to alleviate stress associated with HbSS
patients. Hence, the plant extract treatment may en-
hance HbSS blood stability and patient health. This
study also revealed that the antisickling properties of
these plants might function by modulating the genes re-
sponsible for LDH synthesis in both sexes. The wide
variation of LDH activities between both sexes is
expected as indicated in the control. Genetic differences
between both sexes had been linked to the wide vari-
ation [35]. This wide variation in LDH activity between
both sexes was similarly manifested only in the samples
treated with Cari-oil (Table 4). This is obviously due to
the fact that the seed oil could only generate a mild ef-
fect in modulating the genes that coded for LDH in
male. The same seed oil also generated drastic effect in
modulating the genes that code for LDH in female sub-
jects. This insignificant variation in LDH activity in
males as against a remarkable variation in females had
also been reported [36].Catalase
The catalase enzyme is an endogenous antioxidant
present in all aerobic cells and facilitates the removal of
toxic hydrogen peroxide by catalyzing its decomposition
to molecular oxygen and water, without the production
of free radicals [37]. It is therefore useful as a defense
agent against oxidative stress [37]. High amounts of free
radicals are important in the development of SCD com-
plications and other disease states [38]. High catalase ac-
tivity also suggests poor health status of the blood [38].
Catalase activity is induced by the presence of its sub-
strate, hydrogen peroxide. Thus, a strong antioxidant
should reduce catalase activity as shown by glutathione
treatment (Table 5).d healthy blood
Catalase activity (μmol H2O2/min)
r Sickle cell blood
Female Male Female
2.53 ± 46.10 9.24 ± 4.44 36.27 ± 16.11
8.0 ± 8.95 3.20 ± 2.75 8.00 ± 7.47
9.87 ± 2.13 44.09 ± 12.94 22.16 ± 6.90
8.40 ± 11.27 19.91 ± 9.619 22.04 ± 2.46
3.87 ± 3.70 14.93 ± 5.64 15.64 ± 3.26
0.53 ± 14.93 25.60 ± 10.67 25.60 ± 8.11
Table 6 Peroxidase activity in plant extract-treated sickle cell and healthy blood
Treatment Peroxidase activity (× 10-5 Unit/sec)
Healthy blood donor Sickle cell blood
Male Female Male Female
Control 5.46 ± 4.00 3.46 ± 2.00 2.89 ± 1.60 3.83 ± 1.93
Glutathione 8.07 ± 1.10 6.37 ± 0.49 4.76 ± 2.89 5.83 ± 1.10
Vernonia amygdalina 10.00 ± 0.00 8.00 ± 0.09 3.62 ± 1.90 2.47 ± 1.60
Ipomoea involucrata 18.06 ± 2.40 15.16 ± 3.11 3.74 ± 1.02 7.49 ± 2.90
Solenostemon monostachyus 2.09 ± 0.60 3.19 ± 0.77 2.14 ± 0.20 3.43 ± 1.90
Carica papaya seed oil 62.30 ± 18.00 57.30 ± 11.30 17.24 ± 6.90 19.85 ± 5.40
Data expressed as mean ± SD (n = 10).
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the NBF in this work is similar to earlier reports [39,40].
These difference was attributed to be due to aging since
aging decreases catalase gene transcription in male while
in female, aging leads to an increase in the translational
efficiency of catalase mRNA [41]. Glutathione and the
Ipocrata, VerMyg, Cari-oil and SolMon plant extracts
reduced the catalase activity in NBF. However, the Cari-
oil, VerMyg, and Ipocrata extracts were less effective
than glutathione. Although Cari-oil, Ipocrata and gluta-
thione reduced catalase activity in NBM, VerMyg
reduced the antioxidant status of male blood by increas-
ing its catalase activity. The antioxidant potential of
glutathione was more effective than SolMon in NBM
(Table 5).
However, Ipocrata, VerMyg, Cari-oil and SolMon plant
extracts had no significant effect on the catalase activity
of either male or female sickle cell blood (Table 5). The
fact that the plant extracts were effective in healthy
blood indicates that higher hydrogen peroxide substrate
concentrations than were used in this study (0.5% w/v),
may be required for plant extracts to be effective in re-
ducing catalase activity in sickle cell blood [42]. Alterna-
tively, catalase inhibitors such as β-mercaptoethanol and
dithiothreitol may be abundantly present in HbSS
patients. These inhibitors possess the ability to modify
cysteine residues in the catalase enzyme. Some catalase
inhibitors are thiol compounds that can also modify the
heme group of catalase, and may suggest the cause of
enzyme inactivation in sickle cell patient blood [43].Peroxidase activity
Peroxidase activity normally increases in response to
increased substrate (hydrogen peroxide) concentrations
in the blood [44]. However, only SolMon exhibited ef-
fective antioxidant activity by reducing the peroxidase
enzyme levels in NBM and NBF (Table 6). Cari-oil and
Ipocrata treatment of NBM and NBF blood may encour-
age free radical generation (H2O2) since treatment
increased peroxidase activity (Table 6). Similar freeradical generation effects were also observed for the
Cari-oil extract-treated HbSSM and HbSSM blood
(Table 6).
Conclusions
The positive effects exhibited by all plant extracts in re-
ducing LDH activity were independent of the sex of
HbSS patients. However, the effects on other biochem-
ical indices (enzymes) considered in this study were sex
dependent. While all plant extracts were effective in en-
hancing HbSS polymerization inhibition in females, only
SolMon and Ipocrata were effective in male HbSS blood.
In addition, all the plant extracts may be harmful to
SCD patients’ blood since they increased catalase activity
in HbSSM blood, whereas only Ipomoea may be harmful
to SCD patients’ blood since it increased catalase activity
in HbSSF blood. Furthermore, Cari-oil positively modu-
lated peroxidase activity in both HbSS sexes, whereas
only SoleMon positively modulated peroxidase in male
HbSS blood. Thus, the effectiveness of these plants in
managing SCD is generally dependent on the sex of the
HbSS patients, and this should be considered when
administering plant extracts for the management of
SCD.
Future studies should isolate and study the bioactive
compounds responsible for the antisickling potential in
these plants. Anthocyanins have recently been impli-
cated in the antisickling properties of plants [5]. The
methanolic extract of S. monostachyus and I. involucrata
leaves, and that of C. papaya seed oil had individual
advantages relative to each other, which were manifest
in their antisickling properties. The combination of these
plant extracts may be employed for the management of
SCD to take advantage of their possible synergistic
effects.
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